BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2011
View Archived Issues
Interim first-in-human data released on two c-Met inhibitors
Read More
Trial determines phase II doses of ixabepilone/cisplatin combination regimen in NSCLC
Read More
Halozyme discloses clinical results on new Herceptin formulation
Read More
Pulmonary Fibrosis Foundation to fund independent evaluation of Compugen's candidate for IPF
Read More
Orantinib advances through studies in NSCLC and breast cancer
Read More
U.S. universities assess CDME in model of cystinuria
Read More
Analyses focus on cardiovascular risk with naltrexone/bupropion
Read More
Novel B-raf inhibitors disclosed by Boehringer Ingelheim
Read More
Phase I study of PPI-668 commences
Read More
CSIR presents new antitumor agents
Read More
Takeda commences international phase III program for TAK-875
Read More
Lpath begins dosing in second proof-of-concept iSONEP trial
Read More
Studies confirm efficacy of Transcend-trastuzumab conjugate in HER2-positive breast cancer
Read More
Encore Therapeutics completes proof-of-concept study of ETI-511
Read More
Novel vitamin D receptor ligands synthesized at WARF
Read More
FDA clears IsoAmp HSV assay
Read More
Nile Therapeutics completes dosing in subcutaneous cenderitide trial
Read More
Phase I MultiStem study advances
Read More
Actelion Pharmaceuticals reports new prostanoid DP2 receptor antagonists
Read More
FDA approves MethylGene's IND for new study of antifungal product candidate
Read More
Lux Biosciences withdraws Luveniq MAA
Read More
Almirall and Lundbeck enter agreement to copromote escitalopram
Read More
EMA delays review of Flutiform MAA
Read More
Isotechnika receives scientific advice from EMA for voclosporin trial
Read More
Malaria vaccine RTS,S/ASO1E shows efficacy in African children
Read More